Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/GA/Savannah
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Savannah, GA

Studies commonly pay $75 to $4,500 per completed study

169 clinical trials are currently recruiting participants within 30 miles of Savannah. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

169studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Savannah right now

Top 25 of 169 recruiting studies, sorted by proximity — each links to its official registry page

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler — Savannah, Georgia (6.1 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Atopic Dermatitis N/A Observational 1,000 participants sought
Galderma Investigational Site 7106 — Bluffton, South Carolina (23.7 mi) · Sponsor: Galderma R&D
See eligibility & contact on ClinicalTrials.gov (NCT06988605)

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

Asthma Phase 3 Interventional 231 participants sought
Research Site — Savannah, Georgia (6.1 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06023589)

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

Irritability Associated With Autism Spectrum Disorder Phase 3 Interventional 160 participants sought
CenExeli Research LLC — Savannah, Georgia (6.1 mi) · Sponsor: Intra-Cellular Therapies, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06690398)

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

Bipolar Disorder Type I With Mania Phase 3 Interventional 450 participants sought
CenExel iResearch, LLC — Savannah, Georgia (6.1 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT06929273)

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

Hemophilia A With Inhibitor, Hemophilia B With Inhibitor Phase 4 Interventional 55 participants sought
Willett Children's Hospital at Memorial University Medical Center — Savannah, Georgia (6.1 mi) · Sponsor: American Thrombosis and Hemostasis Network
See eligibility & contact on ClinicalTrials.gov (NCT04647227)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06172296)

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8 Phase 3 Interventional 474 participants sought
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler — Savannah, Georgia (6.1 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05624996)

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive N/A Interventional 739 participants sought
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler — Savannah, Georgia (6.1 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03723928)

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer Phase 3 Interventional 600 participants sought
Summit Cancer Care PC — Savannah, Georgia (6.1 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06793215)

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Macular Degeneration, Age-Related Macular Degeneration Phase 2, Phase 3 Interventional 960 participants sought
Charleston Neuroscience Institute - Bluffton (Site 124) — Bluffton, South Carolina (23.7 mi) · Sponsor: EyeBiotech Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT07440225)

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

High Grade Osteosarcoma, Localized Osteosarcoma Phase 2, Phase 3 Interventional 1,122 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05691478)

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis Phase 3 Interventional 675 participants sought
Aeroallergy Research Laboratory /ID# 267247 — Savannah, Georgia (6.1 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06461897)

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer Phase 2 Interventional 150 participants sought
Memorial University Medical Center /ID# 272467 — Savannah, Georgia (6.1 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06568939)

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Atherosclerotic Cardiovascular Disease, Overweight Phase 3 Interventional 12,800 participants sought
Velocity Clinical Research - Savannah — Savannah, Georgia (6.1 mi) · Sponsor: Amgen
See eligibility & contact on ClinicalTrials.gov (NCT07037433)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 188 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04671667)

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

Cervical Cancer Phase 3 Interventional 1,023 participants sought
Nancy N. & J.C. Lewis Cancer and Research Pavillion - Research Department ( Site 6005) — Savannah, Georgia (6.1 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT07216703)

Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

Non Small Cell Lung Cancer, Epidermal Growth Factor Receptor Gene Mutation N/A Observational 538 participants sought
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler — Savannah, Georgia (6.1 mi) · Sponsor: PrECOG, LLC.
See eligibility & contact on ClinicalTrials.gov (NCT06538038)

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Moderate to Severe Chronic Obstructive Pulmonary Disease Phase 2, Phase 3 Interventional 1,156 participants sought
Centricity Research Rincon Pulmonology — Rincon, Georgia (18.7 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07363694)

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Chronic Obstructive Pulmonary Disease (COPD) Phase 3 Interventional 990 participants sought
Research Site — Rincon, Georgia (18.7 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06883305)

A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1

HIV-1-infection Phase 2 Interventional 175 participants sought
Chatham County Health Department — Savannah, Georgia (6.1 mi) · Sponsor: Gilead Sciences
See eligibility & contact on ClinicalTrials.gov (NCT07645287)

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

Relapsing Multiple Sclerosis Phase 3 Interventional 800 participants sought
TG Therapeutics Investigational Trial Site — Savannah, Georgia (6.1 mi) · Sponsor: TG Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05877963)
Actively enrolling

Studies you may be able to join near Savannah

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for severe chronic itching

Enrolling adults aged 18 to 90 who have had chronic itching for six months or longer. Not open to itching caused by atopic dermatitis, psoriasis, chronic kidney disease, notalgia paresthetica or medication, nor to people with an autoimmune condition such as lupus, Crohn's disease, ulcerative colitis or rheumatoid arthritis.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research studies for chronic kidney disease

This research platform is enrolling Black and African American adults in eligible areas who have been diagnosed with chronic kidney disease. Compensation may be available. The study team confirms eligibility before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Savannah

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Velocity Clinical Research

★ 4.8
340 Eisenhower Dr Ste 1500, Savannah, GA 31406
(912) 443-4253
"There wasn't anything that I had to do except report if I had any flu findings."
— Sylvia Oliver, 5★

CenExel Savannah GA

★ 5.0
6349 Abercorn St, Savannah, GA 31405
(912) 744-0800
"Great place. Friendly and professional!"
— scott parker, 5★

Iresearch Savannah

6349 Abercorn St, Savannah, GA 31405

Fellows Research Alliance Inc

★ 5.0
1 Oglethorpe Professional Blvd Ste 204, Savannah, GA 31406
(912) 355-4447
"Extremely professional and knowledgeable."
— Angela Williams, 5★

Velocity Clinical Research

230 E Derenne Ave, Savannah, GA 31405
(912) 790-4036

Nancy N. and J.C Lewis Cancer & Research Pavilion

★ 4.8 (1164 reviews)
225 Candler Dr, Savannah, GA 31405
(912) 819-5704
"Caring and kind professionals dispensing intravenous chemical cocktails to those of us that require it with a smile and kind inspiration. These hardw…"
— DEBRA GOLDBERG, 5★

SouthCoast Health Savannah Campus Building 1

★ 4.9
1326 Eisenhower Dr, Savannah, GA 31406
(912) 691-4100

SouthCoast Health Savannah Campus Building 2

★ 4.9
1326 Eisenhower Dr Bldg 2, Savannah, GA 31406
(912) 691-3600
"Dr. Bhavesh Patel was kind, professional, and took the time to listen to my concerns. He explained everything clearly and made me feel comfortable th…"
— Rahee, 5★

ExperCARE Urgent Care & Primary Care

★ 4.7
318 Mall Blvd Suite 300B, Savannah, GA 31406
(912) 358-1515
"They were quick to see me, kind with good customer service, courteous, and listened to and addressed all my concerns. They made sure to check and per…"
— Soul Q Original, 5★

Clinical trials in Savannah: what's recruiting

The Savannah area currently has 169 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Savannah, the most active research areas are:

  • Cancer & Oncology12 studies
  • Lungs & Breathing3 studies
  • Immune & Skin2 studies
  • Brain & Mental Health2 studies
  • Heart & Vascular2 studies

Every listing shows the study phase, the recruiting site and its distance from Savannah, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Savannah

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Savannah participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Savannah pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Savannah?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Savannah safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Savannah, GA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Savannah?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Paid clinical trials near Savannah

Other metros within reach

Charleston, SC733 Augusta, GA182 Jacksonville, FL903 Columbia, SC197 Warner Robins, GA73 Gainesville, FL543 Macon, GA73 Myrtle Beach, SC89

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Savannah Severe Chronic Pruritus in Savannah Chronic Kidney Disease (HealthMatch) in Savannah Bladder Issues Due To Spinal Cord Injury in Savannah All conditions

More of GA

Atlanta1,693 Augusta182 Gainesville152 Macon73 Warner Robins73 Athens71 Columbus67

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts